Nitib 140® Ibrutinib Capsules

Nitib 140 mg contains ibrutinib, a targeted medicine used to treat certain blood cancers, including chronic lymphocytic leukaemia (CLL), mantle cell lymphoma and Waldenström's macroglobulinaemia. It works by blocking Bruton tyrosine kinase (BTK), a protein involved in the growth and survival of cancer cells.

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.